One monthly, tasty chew provides broad-spectrum parasite cover
against these key parasites:†
Click on each parasite to find out more
NexGard Spectra® is a prescription only medicine. This site is provided as an information service for veterinary professionals. Please tick ‘I’m a veterinary professional’ to confirm that you are a veterinary professional (e.g. veterinary surgeon, veterinary nurse or veterinary student).
One monthly, tasty chew provides broad-spectrum parasite cover
against these key parasites:†
Click on each parasite to find out more
AFOXOLANER
Eliminates
fleas
Terminates
ticks
Manages
mites†
MILBEMYCIN OXIME
Controls
roundworms
Prevents
lungworm
disease
Also covers
Sarcoptic mange
after 2 monthly treatments51
Demodicosis
after 3 monthly treatments§2,3
§ NexGard Spectra®’s mite indication is for treatment of sarcoptic mange and demodicosis. NexGard Spectra® does not cover ear mites. Refer to SPC for specific treatment regimes.
References:
Toxocara is an increasing public health concern
Eggs are very commonly found in public parks and gardens1
1 in 5 dogs has eggs on their paws and coats2
27% of children have Toxocara antibodies3
Exposed children score lower in maths and reading assessments4
Risk of epilepsy is almost doubled5
Risk of asthma is almost tripled6
References:
Can be used on puppies
from just 8 weeks of age and from 2 kg
Five weight ranges
enable appropriate monthly dosing as puppies grow
Monthly dosing follows ESCCAP‡
puppy roundworming recommendations
Handy resources, like posters for your veterinary practice, and materials to support your client communications.
Engage with new puppy owner clients, helping to keep their new family member happy and healthy while building a lifelong connection with your practice.
A FREE online, easy-to-use parasite risk checker that helps owners to help you assess their dog’s individual risk. Enables a timely, risk-based prescribing decision in your busy practice.
Explore our latest programme of focused practice support, WHAT'S THE RISK?, designed to help you implement risk-based prescribing in your busy practice and be in with a chance to WIN AN APPLE® BUNDLE for yourself plus an iPad® for your practice*
* Terms and conditions apply, available at whatstherisk.co.uk or alternatively please call 01344 746957 (UK) or 01 291 3985 (Ireland) or email vetenquiries@boehringer-ingelheim.com for more information and to access a copy. Apple® and iPad® are registered trademarks of Apple Inc., registered in the U.S. and other countries and regions.
* NexGard Spectra® is indicated for the treatment of flea and tick infestations in dogs when the concurrent prevention of heartworm disease, angiostrongylosis and/or treatment of gastrointestinal nematode infestations is indicated. NexGard Spectra®’s mite indication is for treatment of sarcoptic mange and demodicosis. NexGard Spectra® does not cover tapeworm.
** The safety of the veterinary medicinal product has not been established in breeding males. In breeding males, use only according to the benefit-risk assessment by the responsible veterinarian.
† NexGard Spectra® also covers heartworm, hookworms, whipworm and eyeworm. NexGard Spectra®’s mite indication is for treatment of sarcoptic mange, demodicosis and otodectes cynotis. NexGard Spectra® does not cover tapeworm.
‡ European Scientific Counsel Companion Animal Parasites.
NexGard Spectra® contains afoxolaner and milbemycin oxime. UK: POM-V IE: POM. Further information available in the SPC or from Boehringer Ingelheim Animal Health UK Ltd., RG12 8YS, UK. UK Tel: 01344 746959 (sales) or 01344 746957 (technical), IE Tel: 01 291 3985 (all queries). Email: vetenquiries@boehringer-ingelheim.com. NexGard Spectra® is a registered trademark of Boehringer Ingelheim Animal Health France SCS, used under licence. ©2023 Boehringer Ingelheim Animal Health UK Ltd. All rights reserved. Date of preparation: October 2023. UI-CAN-0129-2023. Use Medicines Responsibly.